UNICHEMLAB — Unichem Laboratories Share Price
- IN₹50.29bn
- IN₹51.31bn
- IN₹17.05bn
- 51
- 13
- 92
- 53
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.1 | ||
Price to Tang. Book | 2.1 | ||
Price to Free Cashflow | 59.25 | ||
Price to Sales | 2.68 | ||
EV to EBITDA | 59.47 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -1.14% | ||
Return on Equity | -1.32% | ||
Operating Margin | -1.51% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 11,037.13 | 12,351.35 | 12,698.32 | 13,430.22 | 17,048.95 | n/a | n/a | 7.64% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | -0.02 | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.
Directors
- Prakash Mody CHM
- Pradeep Bhandari CCO
- Rakesh Parikh VFN
- Dilip Kunkolienkar EDR
- Prafull Anubhai NID (83)
- Ramdas Gandhi NID (88)
- Anand Mahajan NID
- B.Kinnera Murthy NID
- Prafull Sheth NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 22nd, 1962
- Public Since
- January 10th, 1995
- No. of Shareholders
- 21,753
- No. of Employees
- 3,194
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
National Stock Exchange of India
- Shares in Issue
- 70,405,750

- Address
- Unichem Bhavan, MUMBAI, 400102
- Web
- https://www.unichemlabs.com/
- Phone
- +91 2266888333
- Auditors
- N. A. Shah Associates LLP
Upcoming Events for UNICHEMLAB
Q1 2026 Unichem Laboratories Ltd Earnings Release
Similar to UNICHEMLAB
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
As of Today at 22:51 UTC, shares in Unichem Laboratories are trading at IN₹714.35. This share price information is delayed by 15 minutes.
Shares in Unichem Laboratories last closed at IN₹714.35 and the price had moved by +38.05% over the past 365 days. In terms of relative price strength the Unichem Laboratories share price has outperformed the S&P BSE 100 Index by +26.9% over the past year.
The overall consensus recommendation for Unichem Laboratories is Sell. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreUnichem Laboratories does not currently pay a dividend.
Unichem Laboratories does not currently pay a dividend.
Unichem Laboratories does not currently pay a dividend.
To buy shares in Unichem Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹714.35, shares in Unichem Laboratories had a market capitalisation of IN₹50.29bn.
Here are the trading details for Unichem Laboratories:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: UNICHEMLAB
Based on an overall assessment of its quality, value and momentum Unichem Laboratories is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Unichem Laboratories is IN₹355.00. That is 50.3% below the last closing price of IN₹714.35.
Analysts covering Unichem Laboratories currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Unichem Laboratories. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +34.09%.
As of the last closing price of IN₹714.35, shares in Unichem Laboratories were trading +8.93% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Unichem Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹714.35.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Unichem Laboratories' management team is headed by:
- Prakash Mody - CHM
- Pradeep Bhandari - CCO
- Rakesh Parikh - VFN
- Dilip Kunkolienkar - EDR
- Prafull Anubhai - NID
- Ramdas Gandhi - NID
- Anand Mahajan - NID
- B.Kinnera Murthy - NID
- Prafull Sheth - NID